Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04267705 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human

Study acronym: PS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study completion pushed from Jan 30, 2026 to Jan 30, 2027v10
  2. Minor Study completion date: Jan 30, 2025 to Jan 30, 2026v9
  3. Minor Study completion date: Jan 30, 2024 to Jan 30, 2025v8
  4. Minor Primary completion date changed from estimate of Sep 30, 2023 to May 30, 2023
    • Study completion date: Sep 30, 2023 to Jan 30, 2024
    v7
  5. Minor Primary and study completion dates: May 31, 2023 to Sep 30, 2023v6
Show 4 earlier versionsHide 4 earlier versions
  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 83 to confirmed 103
    • Site details revised
    v5
  2. Notable Primary completion date: Apr 2022 to May 31, 2023
    • Study completion date: Sep 2022 to May 31, 2023
    v4
  3. Notable Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v3
  4. Minor Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Start date changed from estimate of Feb 2020 to Feb 24, 2020
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Objective 1: Characterize indices of systemic inflammation and gut microbiota composition and function after chronic (12 weeks) intake of pulses compared to control diet in human OW/OB-IR participants. Objective 2: Characterize dietary- and microbial-derived metabolite pools after regular intake of pulses (12 weeks) in human participants with OW/OB-IR compared to control diet. Objective 3: Characterize cognitive functioning after chronic (12 weeks) intake of pulses compared to control diet in human OW/OB-IR participants.
Trial Details
NCT Number NCT04267705
Lead Sponsor Clinical Nutrition Research Center, Illinois Institute of Technology
Collaborators: USDA Beltsville Human Nutrition Research Center
Conditions
(from sponsor)
Insulin Sensitivity, Overweight or Obesity, Inflammatory Response
Related terms Insulin Resistance, Obesity, Overweight
Enrollment 103 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov